Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus.
Fatykhova D, Fritsch VN, Siebert K, Methling K, Lalk M, Busche T, Kalinowski J, Weiner J, Beule D, Bertrams W, Kohler TP, et al. (2024)
The European respiratory journal.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Fatykhova, Diana;
Fritsch, Verena N;
Siebert, Keerthana;
Methling, Karen;
Lalk, Michael;
Busche, TobiasUniBi;
Kalinowski, JörnUniBi;
Weiner, January;
Beule, Dieter;
Bertrams, Wilhelm;
Kohler, Thomas P;
Hammerschmidt, Sven
Alle
Alle
Abstract / Bemerkung
Streptococcus pneumoniae (S.p.) is the most common causative agent of community-acquired pneumonia worldwide. A key pathogenic mechanism that exacerbates severity of disease is the disruption of the alveolar-capillary barrier. However, the specific virulence mechanisms responsible for this in the human lung are not yet fully understood.In this study, we infected living human lung tissue with S.p. and observed a significant degradation of the central junctional proteins occludin and VE-cadherin, indicating barrier disruption. Surprisingly, neither pneumolysin, bacterial hydrogen peroxide nor pro-inflammatory activation were sufficient to cause this junctional degradation. Instead, pneumococcal infection led to a significant decrease of pH (approximately 6), resulting in acidification of the alveolar microenvironment, which was linked to junctional degradation. Stabilising the pH at physiological levels during infection reversed this effect, even in a therapeutic-like approach.Further analysis of bacterial metabolites and RNA sequencing revealed sugar consumption and subsequent lactate production were the major factors contributing to bacterially induced alveolar acidification, which also hindered the release of critical immune factors.Our findings highlight bacterial metabolite-induced acidification as an independent virulence mechanism for barrier disruption and inflammatory dysregulation in pneumonia. Thus, our data suggest that strictly monitoring and buffering alveolar pH during infections caused by fermentative bacteria could serve as an adjunctive therapeutic strategy for sustaining barrier integrity and immune response. Copyright ©The authors 2024. For reproduction rights and permissions contact permissions@ersnet.org.
Erscheinungsjahr
2024
Zeitschriftentitel
The European respiratory journal
ISSN
0903-1936
eISSN
1399-3003
Page URI
https://pub.uni-bielefeld.de/record/2992371
Zitieren
Fatykhova D, Fritsch VN, Siebert K, et al. Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. The European respiratory journal. 2024.
Fatykhova, D., Fritsch, V. N., Siebert, K., Methling, K., Lalk, M., Busche, T., Kalinowski, J., et al. (2024). Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. The European respiratory journal. https://doi.org/10.1183/13993003.01983-2023
Fatykhova, Diana, Fritsch, Verena N, Siebert, Keerthana, Methling, Karen, Lalk, Michael, Busche, Tobias, Kalinowski, Jörn, et al. 2024. “Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus.”. The European respiratory journal.
Fatykhova, D., Fritsch, V. N., Siebert, K., Methling, K., Lalk, M., Busche, T., Kalinowski, J., Weiner, J., Beule, D., Bertrams, W., et al. (2024). Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. The European respiratory journal.
Fatykhova, D., et al., 2024. Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. The European respiratory journal.
D. Fatykhova, et al., “Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus.”, The European respiratory journal, 2024.
Fatykhova, D., Fritsch, V.N., Siebert, K., Methling, K., Lalk, M., Busche, T., Kalinowski, J., Weiner, J., Beule, D., Bertrams, W., Kohler, T.P., Hammerschmidt, S., Lowa, A., Fischer, M., Mieth, M., Hellwig, K., Frey, D., Neudecker, J., Rueckert, J.C., Toennies, M., Bauer, T.T., Graff, M., Tran, H.-L., Eggeling, S., Gruber, A.D., Antelmann, H., Hippenstiel, S., Hocke, A.C.: Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus. The European respiratory journal. (2024).
Fatykhova, Diana, Fritsch, Verena N, Siebert, Keerthana, Methling, Karen, Lalk, Michael, Busche, Tobias, Kalinowski, Jörn, Weiner, January, Beule, Dieter, Bertrams, Wilhelm, Kohler, Thomas P, Hammerschmidt, Sven, Lowa, Anna, Fischer, Mara, Mieth, Maren, Hellwig, Katharina, Frey, Doris, Neudecker, Jens, Rueckert, Jens C, Toennies, Mario, Bauer, Torsten T, Graff, Mareike, Tran, Hong-Linh, Eggeling, Stephan, Gruber, Achim D, Antelmann, Haike, Hippenstiel, Stefan, and Hocke, Andreas C. “Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus.”. The European respiratory journal (2024).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Quellen
PMID: 39231629
PubMed | Europe PMC
Suchen in